Annette Bley
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Annette Bley has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Alfried Kohlschütter
Klinik für Kinder- und Jugendmedizin, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Deutschland
1 shared publication - Benjamin Dreyer
Department of Pediatrics, University Medical Center Eppendorf, Martinistraße 52, 20246 Hamburg, Germany
1 shared publication - Birgit Kustermann-Kuhn
Department of Paediatric Neurology and Developmental Medicine, University Children’s Hospital, Hoppe-Seyler-Strasse 1, 72076 Tübingen, Germany
1 shared publication - Christian Posern
Department of Pediatrics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
1 shared publication - Christiane Kehrer
Department of Paediatric Neurology and Developmental Medicine, University Children’s Hospital, Tübingen, Germany
1 shared publication - Florian S. Eichler
Department of Neurology, Massachusetts General Hospital, Boston, MA, USA
1 shared publication
Latest Publications
- Open Access
- 3 May 2024
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 142 (2) , 108489
Quantification of N-acetyl-l-aspartate in dried blood spots: A simple and fast LC-MS/MS neonatal screening method for the diagnosis of Canavan disease
- 3 May 2024
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 142 (2) , 108489
Open AccessQuantification of N-acetyl-l-aspartate in dried blood spots: A simple and fast LC-MS/MS neonatal screening method for the diagnosis of Canavan disease
- Open Access
- 1 January 2014
- Published by Springer Nature in Orphanet Journal of Rare Diseases
- Vol. 9 (1) , 18
Language and cognition in children with metachromatic leukodystrophy: onset and natural course in a nationwide cohort
Metachromatic leukodystrophy (MLD) is a rare, genetic neurodegenerative disease. It leads to progressive demyelination resulting in regression of development and early death. With regard to experimental therapies, knowledge of the natural course of the disease is highly important. We aimed to analyse onset and character of first symptoms in MLD and to provide detailed natural course data concerning language and cognition.
- 1 January 2014
- Published by Springer Nature in Orphanet Journal of Rare Diseases
- Vol. 9 (1) , 18
Open AccessLanguage and cognition in children with metachromatic leukodystrophy: onset and natural course in a nationwide cohort
Metachromatic leukodystrophy (MLD) is a rare, genetic neurodegenerative disease. It leads to progressive demyelination resulting in regression of development and early death. With regard to experimental therapies, knowledge of the natural course of the disease is highly important. We aimed to analyse onset and character of first symptoms in MLD and to provide detailed natural course data concerning language and cognition.